HALOZYME THERAPEUTICS, INC. Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Halozyme Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • Halozyme Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was 20.5 %, a 46.1% increase year-over-year.
  • Halozyme Therapeutics, Inc. annual Return On Assets for 2023 was 15.8 %, a 29.9% increase from 2022.
  • Halozyme Therapeutics, Inc. annual Return On Assets for 2022 was 12.2 %, a 67.7% decline from 2021.
  • Halozyme Therapeutics, Inc. annual Return On Assets for 2021 was 37.6 %, a 54.7% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 20.5 +6.47 +46.1% Jul 1, 2024 Sep 30, 2024
Q2 2024 18.1 +5.19 +40.1% Apr 1, 2024 Jun 30, 2024
Q1 2024 17.5 +7.41 +73.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 15.8 +3.63 +29.9% Oct 1, 2023 Dec 31, 2023
Q3 2023 14 -0.27 -1.89% Jul 1, 2023 Sep 30, 2023
Q2 2023 13 -15 -53.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 10.1 -28.7 -74% Jan 1, 2023 Mar 31, 2023
Q4 2022 12.2 -25.5 -67.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 14.3 -29.3 -67.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 28 -1.56 -5.28% Apr 1, 2022 Jun 30, 2022
Q1 2022 38.9 +13.7 +54.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 37.6 +13.3 +54.7% Oct 1, 2021 Dec 31, 2021
Q3 2021 43.6 +39.5 +967% Jul 1, 2021 Sep 30, 2021
Q2 2021 29.6 +37.7 Apr 1, 2021 Jun 30, 2021
Q1 2021 25.1 +42.5 Jan 1, 2021 Mar 31, 2021
Q4 2020 24.3 +40.5 Oct 1, 2020 Dec 31, 2020
Q3 2020 4.08 +13.7 Jul 1, 2020 Sep 30, 2020
Q2 2020 -8.12 +1.77 +17.9% Apr 1, 2020 Jun 30, 2020
Q1 2020 -17.4 -5.94 -52% Jan 1, 2020 Mar 31, 2020
Q4 2019 -16.2 +1.12 +6.47% Oct 1, 2019 Dec 31, 2019
Q3 2019 -9.65 -19.1 -202% Jul 1, 2019 Sep 30, 2019
Q2 2019 -9.89 -26.4 -160% Apr 1, 2019 Jun 30, 2019
Q1 2019 -11.4 -27.4 -172% Jan 1, 2019 Mar 31, 2019
Q4 2018 -17.3 -34.7 -200% Oct 1, 2018 Dec 31, 2018
Q3 2018 9.44 +39.1 Jul 1, 2018 Sep 30, 2018
Q2 2018 16.5 +59.5 Apr 1, 2018 Jun 30, 2018
Q1 2018 15.9 +59.5 Jan 1, 2018 Mar 31, 2018
Q4 2017 17.4 +53.3 Oct 1, 2017 Dec 31, 2017
Q3 2017 -29.7 +8.86 +23% Jul 1, 2017 Sep 30, 2017
Q2 2017 -43 +0.55 +1.26% Apr 1, 2017 Jun 30, 2017
Q1 2017 -43.5 +6.5 +13% Jan 1, 2017 Mar 31, 2017
Q4 2016 -35.9 +25.3 +41.4% Oct 1, 2016 Dec 31, 2016
Q3 2016 -38.5 +10.7 +21.7% Jul 1, 2016 Sep 30, 2016
Q2 2016 -43.6 -0.04 -0.09% Apr 1, 2016 Jun 30, 2016
Q1 2016 -50 -13.3 -36.3% Jan 1, 2016 Mar 31, 2016
Q4 2015 -61.2 -22.7 -58.9% Oct 1, 2015 Dec 31, 2015
Q3 2015 -49.2 +3.48 +6.61% Jul 1, 2015 Sep 30, 2015
Q2 2015 -43.5 +13.3 +23.4% Apr 1, 2015 Jun 30, 2015
Q1 2015 -36.7 +33.5 +47.7% Jan 1, 2015 Mar 31, 2015
Q4 2014 -38.5 +38.1 +49.7% Oct 1, 2014 Dec 31, 2014
Q3 2014 -52.7 +3.52 +6.27% Jul 1, 2014 Sep 30, 2014
Q2 2014 -56.9 +0.21 +0.37% Apr 1, 2014 Jun 30, 2014
Q1 2014 -70.2 -22.2 -46.3% Jan 1, 2014 Mar 31, 2014
Q4 2013 -76.6 -33.6 -78.4% Oct 1, 2013 Dec 31, 2013
Q3 2013 -56.2 +6.63 +10.6% Jul 1, 2013 Sep 30, 2013
Q2 2013 -57.1 -14.7 -34.8% Apr 1, 2013 Jun 30, 2013
Q1 2013 -48 -20.5 -74.9% Jan 1, 2013 Mar 31, 2013
Q4 2012 -42.9 Oct 1, 2012 Dec 31, 2012
Q3 2012 -62.8 Jul 1, 2012 Sep 30, 2012
Q2 2012 -42.3 Apr 1, 2012 Jun 30, 2012
Q1 2012 -27.4 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.